Please login to the form below

Not currently logged in
Email:
Password:

Entereg gets US approval

The US Food and Drug Administration (FDA) has approved Entereg, a medicine manufactured and developed by Adolor and GlaxoSmithKline (GSK).

The US Food and Drug Administration (FDA) has approved Entereg, a medicine manufactured and developed by Adolor and GlaxoSmithKline (GSK).

The medication has been developed to alleviate the symptoms of post-operative ileus (POI). Following extensive studies conducted into the drug's efficacy and safety, the FDA has approved it for use in patients to restore normal gastrointestinal function after undergoing bowel resection surgery. GSK has called Entereg an important new drug for the company that it can now offer to its hospital costumers.

"This approval of Entereg in POI represents a major milestone for Adolor, and is the culmination of a substantial collaborative effort amongst Adolor. GSK and our clinical investigators," said Michael Dougherty, president and chief executive officer of Adolor.

Entereg has been approved with a Risk Evaluation and Mitigation Strategy (REMS) that means limitations have been placed on dispensing of the drug.

Data collected during clinical testing showed that some patients given a twice-daily 0.5mg dose of Entereg experienced myocardial infarction. The FDA has said that it will monitor the product's performance throughout its life cycle.

21st May 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics